We help leading organizations provide effective non-drug options for mental health
With our digital therapeutics, employers and health plans can lower health care costs, deliver meaningful clinical outcomes, and improve lives.
It’s no secret: Mental health conditions are common, costly, and have far-reaching consequences
of people experience a mental health condition in their lifetime.1
When people don’t have access to mental health care, their employers can spend up to 300% more on health care costs.2
of people with a mental health condition do not get care.3
Trusted by the world’s leading organizations
What our customers say
With the growing number of solutions in the market, securing the necessary budget and contracting process can both be burdensome. With only a one-page form and streamlined billing through the pharmacy budget, we were able to get the approvals we needed to launch Sleepio in just 10 days — it was a simple process.
Sleepio is not just a tool to help employees improve their sleep — it’s a fun and engaging program without the stigma of traditional solutions. Plus, we know better sleep can alleviate feelings of anxiety.
We want all of our staff to be healthy, happy, engaged, and productive — all of which are benefits of a good night’s sleep. That’s why we partnered with Big Health to introduce the Sleepio program. We’ve had a tremendous response from employees who struggle with sleep about how appreciative they are that we’ve launched the program.
Simple to adopt, low-lift engagement
Add coverage to your
Pre-approved by major pharmacy benefit managers, add coverage in as few as 10 days.
Offer access via existing care pathways
Easily reach members at the time of need.
Bill via pharmacy invoice
Deep integrations mean you get to bill for therapeutic use via your pharmacy invoice.
Mental health care with proven outcomes and cost savings
Receive data on improvements in clinical outcomes including sleep, anxiety, stress, and productivity.
Sleepio has been shown to impact health care spending with cost effectiveness increasing over time.4
Reach 30-40% of your population within the first year with optional custom communication support.
Custom population engagement strategies, white-glove customer experience
For the past decade, we’ve been helping large organizations tackle mental health stigma and access barriers with custom-built engagement strategies. From nurses to truck drivers to members working from home or abroad, we’ve got you covered.
You might also enjoy…
Private: Is mental health care truly equitable?
To shed light on how to reduce inequities in mental health care, Big Health’s CEO and Co-founder Peter Hames moderated…
Three lessons from the biggest companies on their approach to mental health
Our benchmark report shows how 35+ of the most innovative companies — representing 2.5 million employees lives — are supporting…
Integrate digital therapeutics into the pharmacy pathway
Effective mental health care via your PBM, faster and easier than ever.
Disclaimer: In accordance with FDA’s Current Enforcement Discretion Policy for Digital Health Devices for Psychiatric Disorders, for patients aged 18 years and older, who are followed by and diagnosed with Insomnia Disorder or Generalized Anxiety Disorder by a medical provider, Sleepio and Daylight can be made available as an adjunct to their usual medical care for Insomnia Disorder or Generalized Anxiety Disorder, respectively. Sleepio and Daylight do not replace the care of a medical provider or the patient’s medication. Sleepio and Daylight have not been cleared by the U.S. Food and Drug Administration (FDA) for these indications. Users are directed to not make any changes to their prescribed medication or other type of medical treatment without seeking professional medical advice.
1. Kessler, R. C., Aguilar-Gaxiola, S., Alonso, J., Chatterji, S., Lee, S., Ormel, J., … & Wang, P. S. (2009). The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiology and Psychiatric Sciences, 18(1), 23-33.
2. Trzcinski, A. (2021, March 15). Forrester. Retrieved from: https://www.forrester.com/report/Invest+Now+Build+A+Resilient+Workforce+By+Prioritizing+Employee+Mental+Health/RES164922.
3. Substance Abuse and Mental Health Services Administration. (2020). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/.
4. Darden, M., Espie, C. A., Carl, J. R., Henry, A. L., Kanady, J. C., Krystal, A. D., & Miller, C. B. (2021). Cost-effectiveness of digital cognitive behavioral therapy (Sleepio) for insomnia: a Markov simulation model in the United States. Sleep, 44(4).